0001628280-22-000416.txt : 20220106
0001628280-22-000416.hdr.sgml : 20220106
20220106095127
ACCESSION NUMBER: 0001628280-22-000416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220104
FILED AS OF DATE: 20220106
DATE AS OF CHANGE: 20220106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huber Reid M
CENTRAL INDEX KEY: 0001607052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 22513828
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN
STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3730 KIRBY DRIVE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 3730 KIRBY DRIVE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_164148067397164.xml
FORM 4
X0306
4
2022-01-04
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001607052
Huber Reid M
C/O BELLICUM PHARMACEUTICALS, INC.
3730 KIRBY DRIVE, SUITE 1200
HOUSTON
TX
77098
1
0
0
0
Common Stock
2022-01-04
4
M
0
19494
0
A
19494
D
Restricted Stock Units
2022-01-04
4
M
0
19494
0
D
Common Stock
19494.0
0
D
Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock.
The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021.
/s/ Richard A. Fair, Attorney-in-Fact
2022-01-06